Literature DB >> 28807510

Angina after percutaneous coronary intervention: The need for precision medicine.

Giampaolo Niccoli1, Rocco Antonio Montone2, Gaetano Antonio Lanza3, Filippo Crea3.   

Abstract

Persistence or recurrence of angina after successful percutaneous coronary intervention (PCI) represent an important clinical issue involving from one fifth to one third of patients undergoing myocardial revascularization at one-year follow-up. A systematic approach to this syndrome is strongly needed. Precision medicine is particularly important in addressing angina after successful PCI because of the multiple underlying causes. Restenosis or coronary atherosclerosis progression explain symptom recurrence after successful PCI in some patients, while functional causes, including vasomotor abnormalities of epicardial coronary arteries and/or coronary microvascular dysfunction, explain symptoms in the remaining patients. In this review, we summarize the mechanisms of persistent or recurrent angina after PCI, proposing a diagnostic algorithm and a systematic therapeutic approach.
Copyright © 2017 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Angina; Microvascular dysfunction; Percutaneous coronary intervention

Mesh:

Year:  2017        PMID: 28807510     DOI: 10.1016/j.ijcard.2017.07.105

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  12 in total

Review 1.  ESC Working Group on Coronary Pathophysiology and Microcirculation position paper on 'coronary microvascular dysfunction in cardiovascular disease'.

Authors:  Teresa Padro; Olivia Manfrini; Raffaele Bugiardini; John Canty; Edina Cenko; Giuseppe De Luca; Dirk J Duncker; Etto C Eringa; Akos Koller; Dimitris Tousoulis; Danijela Trifunovic; Marija Vavlukis; Cor de Wit; Lina Badimon
Journal:  Cardiovasc Res       Date:  2020-03-01       Impact factor: 10.787

Review 2.  Significance of psychosocial factors in cardiology: update 2018 : Position paper of the German Cardiac Society.

Authors:  Christian Albus; Christiane Waller; Kurt Fritzsche; Hilka Gunold; Markus Haass; Bettina Hamann; Ingrid Kindermann; Volker Köllner; Boris Leithäuser; Nikolaus Marx; Malte Meesmann; Matthias Michal; Joram Ronel; Martin Scherer; Volker Schrader; Bernhard Schwaab; Cora Stefanie Weber; Christoph Herrmann-Lingen
Journal:  Clin Res Cardiol       Date:  2019-05-10       Impact factor: 5.460

3.  Predictors of recurrent angina in patients with no need for secondary revascularization.

Authors:  Tian Xu; Ya Li; Li-Ding Zhao; Guo-Sheng Fu; Wen-Bin Zhang
Journal:  World J Emerg Med       Date:  2021

4.  Angina with coronary microvascular dysfunction and its physiological assessment: a review with cases.

Authors:  Pitt O Lim
Journal:  Br J Cardiol       Date:  2022-04-20

5.  Myocardial Microvascular Physiology in Acute and Chronic Coronary Syndromes, Aortic Stenosis, and Heart Failure.

Authors:  Alf I Larsen; William F Fearon; Todd J Anderson; Nico Pijls
Journal:  J Interv Cardiol       Date:  2022-01-26       Impact factor: 1.776

Review 6.  Management of Angina Post Percutaneous Coronary Intervention.

Authors:  Jose B Cruz Rodriguez; Subrata Kar
Journal:  Curr Cardiol Rep       Date:  2020-01-21       Impact factor: 2.931

7.  Machine Learning Identifies Metabolic Signatures that Predict the Risk of Recurrent Angina in Remitted Patients after Percutaneous Coronary Intervention: A Multicenter Prospective Cohort Study.

Authors:  Song Cui; Li Li; Yongjiang Zhang; Jianwei Lu; Xiuzhen Wang; Xiantao Song; Jinghua Liu; Kefeng Li
Journal:  Adv Sci (Weinh)       Date:  2021-03-08       Impact factor: 16.806

Review 8.  Endothelial Dysfunction and Coronary Vasoreactivity - A Review of the History, Physiology, Diagnostic Techniques, and Clinical Relevance.

Authors:  Tharusha Gunawardena; Ioannis Merinopoulos; Upul Wickramarachchi; Vassilios Vassiliou; Simon Eccleshall
Journal:  Curr Cardiol Rev       Date:  2021

9.  Efficacy and safety of Chinese herbal medicine Wen Xin granules for the treatment of unstable angina pectoris with Yang deficiency and blood stasis syndrome: study protocol for a randomized controlled trial.

Authors:  Pan-Pan Tian; Qing-Juan Wu; Jun Li; Heng-Wen Chen; Ji Wu; Ya-Wen Deng; Zi-Cong Xie; Wei Zhao; Yu-Qing Tan
Journal:  Trials       Date:  2021-11-13       Impact factor: 2.279

10.  Effect and safety of Chinese patent medicine capsules for recurrent angina pectoris after percutaneous coronary intervention: A protocol for systematic review and meta-analysis.

Authors:  Yize Sun; Zheyi Wang; Chao Wang; Zhuoran Tang; Jinyu Shi; Haibin Zhao
Journal:  Medicine (Baltimore)       Date:  2020-12-04       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.